Avanzanite Bioscience Appoints Dr. Mark Bechter as SVP of Medical Affairs
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European speciality pharmaceutical company focused on rare diseases, announced on 10th September the appointment of Dr. Mark Bechter as Senior Vice President of Medical Affairs. As the sixth executive leadership hire of 2025, this appointment further strengthens Avanzanite’s “Champions League” team. It also underscores the company’s commitment to […]
